Artelo Biosciences ARTL
NASDAQ ARTL
$2.18 +0.02 (+0.93%)
At close: Nov 11, 2026 · 4:00 PM EST

Artelo Biosciences (ARTL) Long-Term Investments (2021 - 2024)

Updated

Artelo Biosciences' Long-Term Investments came in at $500,000 for Q3 2024, down 95.1% from $10.23 million a year earlier and down 77.5% from the prior quarter.

Analysis

Artelo Biosciences (ARTL) Long-Term Investments (2021 - 2024) Analysis & Trends

At the end of FY2023, Artelo Biosciences' Long-Term Investments was $7.61 million, down 16.8% from FY2022.

  • Going back by year, Long-Term Investments was $9.15 million in FY2022 (-23.4%) and $11.95 million in FY2021.
  • The Q3 2024 figure represents the lowest quarterly Long-Term Investments in data going back to Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.01 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 387.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.60 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 63.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 268.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.45 Bn
10 Artelo Biosciences 49.32 Mn 32.53 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 500,000.00
Jun 30, 2024 2.23 Mn
Dec 31, 2023 7.61 Mn
Sep 30, 2023 10.23 Mn
Jun 30, 2023 8.27 Mn
Mar 31, 2023 8.57 Mn
Dec 31, 2022 9.15 Mn
Nov 30, 2021 1.52 Mn
Aug 31, 2021 3.44 Mn
Feb 28, 2021 512,030.00
API Access

Artelo Biosciences Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=ARTL&period=max&api_key=YOUR_API_KEY